California State Teachers Retirement System (CalSTRS)
AVDL

California State Teachers Retirement System (CalSTRS)’s Avadel Pharmaceuticals AVDL Stock Holding History

California State Teachers Retirement System (CalSTRS)’s Portfolio AVDL Stock Details AVDL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-82,996
Closed -$1.79M – 2942
2025
Q4 		$1.79M Sell
82,996
-4,682
-5% -$90.9K ﹤0.01% 1474
2025
Q3 		$1.34M Buy
87,678
+7,426
+9% +$96.6K ﹤0.01% 1644
2025
Q2 		$710K Sell
80,252
-1,196
-1% -$10.5K ﹤0.01% 1900
2025
Q1 		$638K Hold
81,448
– – ﹤0.01% 1938
2024
Q4 		$856K Buy
81,448
+7,544
+10% +$91.6K ﹤0.01% 1862
2024
Q3 		$969K Buy
73,904
+67,207
+1,004% +$1.02M ﹤0.01% 1795
2024
Q2 		$94.2K Buy
+6,697
New +$109K ﹤0.01% 2409

Other funds holding AVDL

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

California State Teachers Retirement System (CalSTRS)'s AVDL Position: Q1 2026 in Review

California State Teachers Retirement System (CalSTRS) sold out of Avadel Pharmaceuticals (AVDL) in Q1 2026, closing a stake of 82,996 shares — an estimated $1.79M sold.

California State Teachers Retirement System (CalSTRS) first reported a position in AVDL in Q2 2024 and held it in 7 quarters. The position peaked at $1.79M in Q4 2025. 2 funds tracked by Wall St. Rank hold AVDL as of Q1 2026.

  • California State Teachers Retirement System (CalSTRS) reported no remaining Avadel Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • California State Teachers Retirement System (CalSTRS) sold 82,996 Avadel Pharmaceuticals shares in Q1 2026, an estimated $1.79M.
  • California State Teachers Retirement System (CalSTRS) first reported a position in Avadel Pharmaceuticals in Q2 2024 and held it in 7 quarters.
  • California State Teachers Retirement System (CalSTRS)'s Avadel Pharmaceuticals position peaked at $1.79M in Q4 2025.
  • 2 funds tracked by Wall St. Rank held Avadel Pharmaceuticals as of Q1 2026.

Based on California State Teachers Retirement System (CalSTRS)'s 13F filing for Q1 2026, filed 18 May 2026.